Biotech buzz builds up in high schools
September 29, 2005
Most of the attention on Arizona's bioscience industry has focused on the successes of those already in the workforce. In this back-to-school feature we take a look at what high schools have accomplished in building bioscience education programs essential for…
Sneak peek: the Phoenix biosciences high school
September 29, 2005
In August 2006, the new Phoenix Union High School District biosciences high school will open its doors.
Biotech buzz builds up in Arizona high schools
September 29, 2005
Most of the attention on Arizona’s bioscience industry has focused on the successes of those already in the workforce. Keren G. Raz of the Flinn Foundation takes an in-depth look at what high schools have accomplished in building bioscience education…
TGen and Biodesign land $8.9 million NIH grant
September 27, 2005
Arizona State University's Biodesign Institute and the Translational Genomics Research Institute were awarded $8.9 million in federal grants to research methods of screening radiation victims in the event of a terrorist attack. The two will work as part of a…
Biotech firm moves headquarters to Valley
September 13, 2005
Canadian drug-development company InNexus is moving its headquarters and research laboratories to Scottsdale. The Valley beat out Seattle, San Francisco, and San Diego in landing InNexus's headquarters. The move could result in up to 100 jobs for people in the…
C-Path receives Flinn grant of $1.25 million
August 19, 2005
Tucson's Critical Path Institute (C-Path) has received a $1.25 million grant from the Flinn Foundation to support startup operations and scientific and educational programs over the next five years. The new institute, founded by the University of Arizona, U.S. Food…
‘Cowboy spirit’ inspires C-Path director
August 19, 2005
Dr. Ray Woosley has generated a lot of excitement in Arizona with the founding of C-Path. The Tucson-based Critical Path Institute, which has received millions in community support, aims to turn Woosley's vision of revolutionizing the drug development process into…